EBOS Group Limited (ASX:EBO)
22.70
+0.13 (0.58%)
Jan 16, 2026, 4:10 PM AEST
EBOS Group Market Cap
EBOS Group has a market cap or net worth of 4.6 billion as of January 16, 2026. Its market cap has decreased by -31.40% in one year.
Market Cap
4.60B
Enterprise Value
5.91B
Revenue
12.27B
Ranking
n/a
PE Ratio
21.37
Stock Price
22.70
Market Cap Chart
Since August 30, 1999, EBOS Group's market cap has increased from 37.66M to 4.60B, an increase of 12,106.87%. That is a compound annual growth rate of 19.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 4.60B | -5.87% |
| Dec 31, 2025 | 4.88B | -25.18% |
| Dec 31, 2024 | 6.53B | 3.20% |
| Dec 29, 2023 | 6.33B | -18.95% |
| Dec 30, 2022 | 7.81B | 9.56% |
| Dec 31, 2021 | 7.12B | 62.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 83.56B |
| Pro Medicus | 21.90B |
| Cochlear | 17.28B |
| Sonic Healthcare | 11.38B |
| Ramsay Health Care | 8.25B |
| Ansell | 4.82B |
| Telix Pharmaceuticals | 3.73B |
| Mesoblast | 3.50B |